Is there improvement of "vascular depression" after carotid artery stent placement?

Wolfgang Mlekusch1, Irene Mlekusch, Erich Minar

  • 1Department of Internal Medicine II, Vienna General Hospital, Medical School, Waehringer Guertel 18-20, A-1090 Vienna, Austria. wolfgang.mlekusch@meduniwien.ac.at

Radiology
|June 16, 2006
PubMed

Insights

High-grade internal carotid artery stenosis is linked to depression. Carotid artery stenting (CAS) significantly reduced depressive symptoms in patients with atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Psychiatry

Background:

  • High-grade internal carotid artery stenosis (ICAS) is a significant risk factor for stroke.
  • Depressive symptoms are common in patients with cardiovascular disease.
  • The relationship between ICAS and depression requires further investigation.

Purpose of the Study:

  • To determine if high-grade ICAS is associated with depressive symptoms.
  • To evaluate the effect of carotid artery stenting (CAS) on depressive symptoms in patients with ICAS.

Main Methods:

  • Prospective study including 143 patients with high-grade ICAS undergoing CAS and 102 controls with peripheral artery disease.
  • Depressive symptoms assessed using the Beck Depression Inventory (BDI) at baseline and 4-week follow-up.
  • Statistical analysis included chi-squared, Mann-Whitney U, McNemar, Wilcoxon rank sum, and two-group t tests.

Main Results:

  • A higher prevalence of depressive symptoms was observed in patients with ICAS compared to controls at baseline (33.6% vs 16.7%, P = .003).
  • Following CAS, a significant reduction in depressive symptoms was noted in the ICAS group (33.6% vs 9.8%, P < .001).
  • Depressive symptom frequency remained unchanged in the control group (16.7% vs 13.0%, P = .1).

Conclusions:

  • High-grade ICAS is associated with an increased prevalence of depressive symptoms in patients with atherosclerosis.
  • Carotid artery stenting (CAS) appears to have a beneficial impact on depressive symptoms in this patient population.
  • Further research may explore the mechanisms underlying this association and the therapeutic potential of CAS for depression in ICAS patients.
Abstract